ProjectXPF-008-201
Basic data
Title:
XPF-008-201
Duration:
14/03/2020 to 14/03/2023
Abstract / short description:
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability and efficacy of XEN1101 as adjunctive therapy in focal-onset epilepsy, with an open-label extension
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Other staff
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Population-based medicine
Institute of Health Sciences, Faculty of Medicine
Institute of Health Sciences, Faculty of Medicine
Local organizational units
Department of Neurology and Epileptology
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Burnaby, British Columbia, Canada